These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15667396)

  • 1. The emperor has no clothes: dementia treatment on the eve of the aging era.
    Royall DR
    J Am Geriatr Soc; 2005 Jan; 53(1):163-4. PubMed ID: 15667396
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 3. [The practice guideline 'Diagnosis and pharmaceutical treatment of dementia'].
    van Gool WA; Stam CJ; Steenhoek A; Hagemeijer A
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):839-43. PubMed ID: 16676513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
    Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H
    Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.
    Oude Voshaar RC; Burns A; Olde Rikkert MG;
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):29-31. PubMed ID: 16353176
    [No Abstract]   [Full Text] [Related]  

  • 8. When should drug treatment be started for people with dementia?
    Singh B; O'Brien JT
    Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I remember.
    Ladouceur R
    Can Fam Physician; 2006 Feb; 52():155. PubMed ID: 16529383
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 11. [Memantine for the treatment of dementia].
    van Gool WA; Eikelenboom P
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2101-2. PubMed ID: 14619198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of dementia treatment use in assisted living facilities: a cross-sectional study of 1975 demented residents.
    Barro-Belaygues N; Abellan van Kan G; Rolland Y; Nourhashemi F; Soto-Martin M; Gillette-Guyonnet S; Vellas B
    J Am Med Dir Assoc; 2011 Nov; 12(9):648-54. PubMed ID: 21450189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
    Wellhöfer B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychotropic drug treatment in dementia disorders].
    Richartz E; Schott KJ; Wormstall H
    Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1434-40. PubMed ID: 15213876
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of dementia and use of anti-dementia drugs in nursing homes].
    Engedal K
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1188-90. PubMed ID: 15880157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAFP and ACP release guideline on dementia treatment.
    Graham L
    Am Fam Physician; 2008 Apr; 77(8):1173-5. PubMed ID: 18481566
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of the 2011 NICE guidance on dementia drugs in a neurology-led memory clinic.
    Larner AJ
    Clin Med (Lond); 2012 Oct; 12(5):496. PubMed ID: 23101161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.